Symphogen Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IMNM | D | Immunome, Inc. | 5.21 | |
IVVD | F | Invivyd, Inc. | 2.11 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
DWAS | C | PowerShares DWA SmallCap Technical Leaders Portfolio | 0.95 | |
PTH | D | Invesco DWA Healthcare Momentum ETF | 0.69 | |
IWC | B | iShares Microcap ETF | 0.11 | |
FHLC | C | Fidelity MSCI Health Care Index ETF | 0.01 | |
VXF | C | Vanguard Extended Market ETF | 0.01 |
Compare ETFs
Related Industries:
Biotechnology
- Symphogen
Symphogen is a biotechnology company located in Copenhagen, Denmark that develops protein drugs based on recombinant monoclonal antibody mixtures. These drugs are different from the polyclonal antibodies, as each antibody in the mixture is produced from one carefully selected clone. Their three main areas of therapeutic research are immunoglobulin replacement, cancer, and infectious diseases. The company was founded in 2000 and has patents on a drug discovery platform called Symplex and a drug manufacturing platform called Sympress. By 2009, ten drugs were being developed with rozrolimupab (Sym001) being the lead product. Laboratoires Servier acquired Symphogen in 2020.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles